Bridging the Medical Oxygen Access Gap in South-East Asia: A Public Health and Governance Imperative
Context
Medical oxygen is an essential component of modern healthcare, critical for treating conditions like pneumonia, neonatal disorders, trauma, and COVID-19. Yet, despite its importance, access to safe, affordable, and reliable medical oxygen remains severely limited, especially in South Asia and East Asia-Pacific regions, which face service coverage gaps of 78% and 74% respectively. The COVID-19 pandemic further highlighted these deficiencies, exposing systemic weaknesses in oxygen infrastructure across low- and middle-income countries (LMICs), including India.
RelevanceΒ
-
GS Paper II: Governance, Health Sector Reforms
-
Role of the government and WHO in public health infrastructure.
-
International collaboration and capacity building in healthcare delivery.
-
-
GS Paper III: Science & Tech, Disaster Management
-
Role of innovation (solar-powered oxygen systems, PSA plants).
-
Managing public health emergencies through resilient infrastructure.
-
-
Essay Paper / Ethics
-
Ethical dimensions of equitable healthcare.
-
Human rights and dignity in access to essential medicines.
-
Multi-Dimensional Analysis of the Oxygen Access Gap
1. Health Infrastructure Challenges in Medical Oxygen Access
-
Limited Equipment Penetration: Only 54% of LMIC hospitals have pulse oximeters and 58% have access to medical oxygen. This leads to delayed diagnosis, inadequate treatment, and preventable deaths.
-
High Financial Cost: An estimated $6.8 billion is required globally to bridge the oxygen gap; South Asia alone needs $2.6 billion.
-
Shortage of Skilled Workforce: Lack of trained biomedical engineers and technicians hampers the maintenance and operation of oxygen equipment.
2. Policy and Governance Bottlenecks
-
Short-term Emergency Responses: COVID-19 induced a reactive, rather than sustainable, approach.
-
Lack of Long-Term Planning: Many countries lack integrated scale-up plans for oxygen access within Universal Health Coverage (UHC).
-
Weak Regulatory Frameworks: There is a need for standardised safety protocols for storage, production, and delivery.
3. Regional Cooperation and WHO Interventions
-
WHOβs Role: Developed a 2022 report highlighting best practices and initiated regional collaboration (e.g., Nepal training Bhutanese engineers).
-
Oxygen Resolution: WHOβs global call for periodic progress reviews (2026, 2028, 2030).
-
Scorecard and Monitoring Tools: WHO Access to Medical Oxygen Scorecard promotes data-driven accountability.
4. Innovations and Technological Solutions
-
PSA Oxygen Plants: Pressure Swing Adsorption (PSA) plants offer decentralized oxygen production.
-
Solar-Powered Oxygen Systems: Adopted in Ethiopia and Nigeria, these ensure uninterrupted oxygen supply in low-power zonesβideal for South-East Asia.
-
Booster Pumps & Portable Concentrators: Improve last-mile oxygen delivery.
5. Private Sector and Civil Society Involvement
-
Private Investment: Encouraged in local manufacturing to cut import costs and address supply-demand gaps.
-
NGOs and Donors: Must shift from crisis-mode aid to long-term operational support and infrastructure funding.
-
Academia and Research: Need to develop affordable, scalable, low-maintenance oxygen technologies tailored to LMICs.
6. Strategic Policy Actions Needed
-
Integrated Oxygen Ecosystems: National governments must draft and execute oxygen scale-up strategies.
-
Training and Capacity Building: Continuous training for biomedical personnel and plant operators is crucial.
-
Decentralised Manufacturing: Reduces transport cost and improves rural reach.
-
Emergency Preparedness Integration: Oxygen access should be a core part of disaster and health emergency planning.
Conclusion
The oxygen access crisis is not just a public health issueβit is a matter of equity, justice, and human rights. Oxygen, a life-saving medicine with no alternative, should never be a luxury. The pandemic has provided both a warning and a window of opportunity. If we fail to act now, history may repeat itself.
A multi-stakeholder, coordinated, and sustained effortβinvolving governments, WHO, private players, civil society, and academiaβis the only way to ensure equitable oxygen access. South-East Asia, with its high demand and demonstrated capacity for regional collaboration, must lead the way in bridging this gap.





